Correlation Between Faron Pharmaceuticals and Helios Towers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Helios Towers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Helios Towers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Helios Towers Plc, you can compare the effects of market volatilities on Faron Pharmaceuticals and Helios Towers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Helios Towers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Helios Towers.

Diversification Opportunities for Faron Pharmaceuticals and Helios Towers

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Faron and Helios is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Helios Towers Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helios Towers Plc and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Helios Towers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helios Towers Plc has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Helios Towers go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Helios Towers

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to generate 4.73 times more return on investment than Helios Towers. However, Faron Pharmaceuticals is 4.73 times more volatile than Helios Towers Plc. It trades about 0.16 of its potential returns per unit of risk. Helios Towers Plc is currently generating about -0.2 per unit of risk. If you would invest  14,250  in Faron Pharmaceuticals Oy on September 23, 2024 and sell it today you would earn a total of  2,250  from holding Faron Pharmaceuticals Oy or generate 15.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Faron Pharmaceuticals Oy  vs.  Helios Towers Plc

 Performance 
       Timeline  
Faron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Helios Towers Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Helios Towers Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Faron Pharmaceuticals and Helios Towers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Faron Pharmaceuticals and Helios Towers

The main advantage of trading using opposite Faron Pharmaceuticals and Helios Towers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Helios Towers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helios Towers will offset losses from the drop in Helios Towers' long position.
The idea behind Faron Pharmaceuticals Oy and Helios Towers Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets